Here’s Why Conestoga Capital Advisors Sold Mesa Laboratories (MLAB)
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter.
Mesa Laboratories Inc (MLAB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 173,231 | $22,509,636 | 0.01% | |
| 2. | Ranger Investment Management Conrad Doenges (Cio) | 131,431 | $17,078,144 | -25% | 1.6% |
| 3. | Diamond Hill Capital Ric Dillon | 130,173 | $16,914,680 | -17% | 0.18% |
| 4. | Royce & Associates Chuck Royce | 39,598 | $5,145,364 | -66% | 0.05% |
| 5. | Quantinno Capital Hoon Kim | 8,368 | $1,087,338 | +19% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $112.80 | 7,093 | $800,090.40 | 7,093 | 2026-08-13 | Filing | |
| $113.69 | 900 | $102,321.00 | 6,298 | 2026-08-13 | Filing | |
| $76.35 | 1,301 | $99,331.35 | 3,429 | 2026-03-10 | Filing | |
| $76.00 | 1,315 | $99,940.00 | 5,398 | 2026-03-10 | Filing | |
| $200.00 | 500 | $100,000.00 | 500 | 2022-08-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $112.80 | 7,093 | $800,090.40 | 17,834 | 2026-08-13 | Filing | |
| $89.50 | 442 | $39,559.88 | 2,020 | 2026-06-22 | Filing | |
| $89.50 | 2,516 | $225,187.03 | 6,377 | 2026-06-22 | Filing | |
| $89.50 | 2,827 | $253,022.15 | 19,785 | 2026-06-22 | Filing | |
| $101.27 | 1,151 | $116,558.32 | 3,710 | 2026-06-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 457,599 | $59,460,414 | 0% | |
| 2. | 387,129 | $50,303,542 | 0.37% | |
| 3. | 276,565 | $35,936,856 | 0.02% | |
| 4. | 236,214 | $30,693,647 | 0% | |
| 5. | 175,079 | $22,749,796 | 0.01% |
News See All
Diamond Hill Capital Small Cap Strategy’s Views on Mesa Laboratories (MLAB)
Diamond Hill Capital, an investment management company, released its “Small Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
What Makes Mesa Laboratories (MLAB) a Valuable Stock?
Diamond Hill Capital, an investment management company, released its “Small Cap Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance
Conestoga Capital Advisors, an asset management company, released its “Micro-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Andvari Sold One of its Longest Holdings Mesa Laboratories (MLAB) in Q2
Andvari Associates, an investment management firm, released its second quarter 2024 investor letter, a copy of which can be downloaded here.
Mesa Laboratories (MLAB) Impacted by Slowdown in Pharmaceutical And Biotech Spending
Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
15 Worst Performing Growth Stocks in 2023
In this piece, we will take a look at the fifteen worst performing growth stocks in 2023.
Here’s Why Mesa Laboratories (MLAB) Declined in Q2
Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2023 investor letter. A copy of the same can be downloaded here.
Is Mesa Laboratories (MLAB) a Growing Stock?
Andvari Associates, an investment management company, released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here.
Here's Why Mesa Laboratories (MLAB) Declined in Q3
Conestoga Capital Advisors, an asset management company, released its “Small Cap Growth Fund” third-quarter investor letter. A copy of the same can be downloaded here.
Hedge Fund Resource Center